E3 ubiquitin ligases and deubiquitinases as modulators of TRAIL-mediated extrinsic apoptotic signaling pathway

키워드

참고문헌 (76)

1. Hershko A, "The ubiquitin system", Annu Rev Biochem, 67, pp.425~479 (1998)
2. Pickart CM, "Mechanisms underlying ubiquitination", Annu Rev Biochem, 70, pp.503~533 (2001)
3. Finley D, "Ubiquitin as a central cellular regulator", Cell, 116, pp.S29~S32 (2004)[DOI]
4. Ravid T, "Diversity of degradation signals in the ubiquitin-proteasome system", Nat Rev Mol Cell Biol, 9, pp.679~690 (2008)
5. Deshaies RJ, "RING domain E3ubiquitin ligases", Annu Rev Biochem, 78, pp.399~434 (2009)
6. Joazeiro CA, "RING finger proteins : mediators of ubiquitin ligase activity", Cell, 102, pp.549~552 (2000)
7. Ikeda F, "Atypical ubiquitin chains : new molecular signals. 'Protein Modifications : Beyond the Usual Suspects' review series", EMBO Rep, 9, pp.536~542 (2008)
8. Kulathu Y, "Atypical ubiquitylation-the unexplored world of polyubiquitin beyond Lys48and Lys63 linkages", Nat Rev Mol Cell Biol, 13, pp.508~523 (2012)
9. Olzmann JA, "Parkin-mediated K63-linked polyubiquitination : a signal for targeting misfolded proteins to the aggresome-autophagy pathway", Autophagy, 4, pp.85~87 (2008)
10. Shen M, "Targeting the ubiquitin-proteasome system for cancer therapy", Expert Opin Ther Targets, 17, pp.1091~1108 (2013)
11. Ding F, "The role of the ubiquitin-proteasome pathway in cancer development and treatment", Front Biosci (Landmark Ed), 19, pp.886~895 (2014)
12. Orlowski RZ, "The role of the ubiquitin-proteasome pathway in apoptosis", Cell Death Differ, 6, pp.303~313 (1999)
13. Reyes-Turcu FE, "Regulation and cellular roles of ubiquitin-specific deubiquitinating enzymes", Annu Rev Biochem, 78, pp.363~397 (2009)
14. Leznicki P, "Mechanisms of regulation and diversification of deubiquitylating enzyme function", J Cell Sci, 130, pp.1997~2006 (2017)
15. Nijman SM, "A genomic and functional inventory of deubiquitinating enzymes", Cell, 123, pp.773~786 (2005)
16. Clague MJ, "Deubiquitylases from genes to organism", Physiol Rev, 93, pp.1289~1315 (2013)
17. Komander D, "Breaking the chains : structure and function of the deubiquitinases", Nat Rev Mol Cell Biol, 10, pp.550~563 (2009)
18. Abdul Rehman SA, "MINDY-1 is a member of an evolutionarily conserved and structurally distinct new family of deubiquitinating enzymes", Mol Cell, 63, pp.146~155 (2016)
19. Bielskiene K, "E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma", Medicina (Kaunas), 51, pp.1~9 (2015)
20. D'Arcy P, "Deubiquitinase inhibition as a cancer therapeutic strategy", Pharmacol Ther, 147, pp.32~54 (2015)
21. Nicholson B, "Deubiquitinating enzymes as novel anticancer targets", Future Oncol, 3, pp.191~199 (2007)
22. Ashkenazi A, "Safety and antitumor activity of recombinant soluble Apo2 ligand", J Clin Invest, 104, pp.155~162 (1999)
23. Walczak H, "Tumoricidal activity of tumor necrosis factor-related apoptosisinducing ligand in vivo", Nat Med, 5, pp.157~163 (1999)
24. Wang S, "TRAIL and apoptosis induction by TNF-family death receptors", Oncogene, 22, pp.8628~8633 (2003)
25. Pan G, "The receptor for the cytotoxic ligand TRAIL", Science, 276, pp.111~113 (1997)
26. Sheridan JP, "Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors", Science, 277, pp.818~821 (1997)
27. Srivastava RK, "TRAIL", Apo-2L : mechanisms and clinical applications in cancer, 2001, pp.3, 535~546
28. Kischkel FC, "Apo2L", TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5, 2000, pp.12, 611~620
29. Kantari C, "Caspase-8 and bid : caught in the act between death receptors and mitochondria", Biochim Biophys Acta, 1813, pp.558~563 (2011)
30. Zhang L, "Mechanisms of resistance to TRAIL-induced apoptosis in cancer", Cancer Gene Ther, 12, pp.228~237 (2005)
31. Jin Z, "Deficient tumor necrosis factor-related apoptosisinducing ligand(TRAIL)death receptor transport to the cell surface in human colon cancer cells selected for resistance to TRAIL-induced apoptosis", J Biol Chem, 279, pp.35829~35839 (2004)
32. Zhang Y, "TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5", Mol Cancer Res, 6, pp.1861~1871 (2008)
33. Song JJ, "c-Cbl-mediated degradation of TRAIL receptors is responsible for the development of the early phase of TRAIL resistance", Cell Signal, 22, pp.553~563 (2010)
34. Kim SY, "c-Cbl shRNAexpressing adenovirus sensitizes TRAIL-induced apoptosis in prostate cancer DU-145 through increases of DR4", 5, 2013, pp.20, 82~87
35. van de Kooij B, "Ubiquitination by the membrane-associated RING-CH-8(MARCH-8)ligase controls steady-state cell surface expression of tumor necrosis factor-related apoptosis inducing ligand(TRAIL)receptor 1", J Biol Chem, 288, pp.6617~6628 (2013)
36. Park EJ, "Chloroquine enhances TRAIL-mediated apoptosis through up-regulation of DR5 by stabilization of mRNA and protein in cancer cells", Sci Rep, 6, pp.22921~ (2016)
37. D'Arcy P, "Proteasome deubiquitinases as novel targets for cancer therapy", Int J Biochem Cell Biol, 44, pp.1729~1738 (2012)
38. D'Arcy P, "Inhibition of proteasome deubiquitinating activity as a new cancer therapy", Nat Med, 17, pp.1636~1640 (2011)
39. Oh YT, "The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5", Sci Rep, 7, pp.8027~ (2017)
40. Oh YT, "Monocyte chemotactic protein-induced protein-1 enhances DR5degradation and negatively regulates DR5 activationinduced apoptosis through its deubiquitinase function", Oncogene, 37, pp.3415~3425 (2018)
41. Jin Z, "Cullin3-based polyubiquitination and p62-dependent aggregation of caspase-8mediate extrinsic apoptosis signaling", Cell, 137, pp.721~735 (2009)
42. Bosu DR, "Cullin-RING ubiquitin ligases : global regulation and activation cycles", Cell Div, 3, pp.7~ (2008)
43. Petroski MD, "Function and regulation of cullin-RING ubiquitin ligases", Nat Rev Mol Cell Biol, 6, pp.9~20 (2005)
44. Gonzalvez F, "TRAF2 Sets a threshold for extrinsic apoptosis by tagging caspase-8with a ubiquitin shutoff timer", Mol Cell, 48, pp.888~899 (2012)
45. Xu L, "DR5-Cbl-b", c-Cbl-TRAF2complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells, 2017, pp.11, 1733~1751
46. Li Y, "The HECTD3 E3ubiquitin ligase facilitates cancer cell survival by promoting K63-linked polyubiquitination of caspase-8", Cell Death Dis, 4, pp.e935~ (2013)
47. Zhou Z, "The WWP1 ubiquitin E3 ligase increases TRAIL resistance in breast cancer", Int J Cancer, 130, pp.1504~1510 (2012)
48. Christian PA, "Possible role of death receptor-mediated apoptosis by the E3 ubiquitin ligases Siah2 and POSH", Mol Cancer, 10, pp.57~ (2011)
49. Bodmer JL, "TRAIL receptor-2 signals apoptosis through FADD and caspase-8", Nat Cell Biol, 2, pp.241~243 (2000)
50. Sprick MR, "FADD", MORT1 and caspase-8 are recruited to TRAIL receptors 1 and 2 and are essential for apoptosis mediated by TRAIL receptor 2, 2000, pp.12, 599~609
51. Lee EW, "Ubiquitination and degradation of the FADD adaptor protein regulate death receptor-mediated apoptosis and necroptosis", Nat Commun, 3, pp.978~ (2012)
52. Chaudhary PM, "Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway", Immunity, 7, pp.821~830 (1997)
53. Hsu H, "TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways", Cell, 84, pp.299~308 (1996)
54. Sessler T, "Structural determinants of DISC function : new insights into death receptor-mediated apoptosis signalling", Pharmacol Ther, 140, pp.186~199 (2013)
55. Christofferson DE, "Control of life-or-death decisions by RIP1 kinase", Annu Rev Physiol, 76, pp.129~150 (2014)
56. Wertz IE, "De-ubiquitination and ubiquitin ligase domains of A20downregulate NF-kappaB signalling", Nature, 430, pp.694~699 (2004)
57. Bellail AC, "A20 ubiquitin ligase-mediated polyubiquitination of RIP1inhibits caspase-8 cleavage and TRAIL-induced apoptosis in glioblastoma", Cancer Discov, 2, pp.140~155 (2012)
58. Dong B, "Targeting A20enhances TRAIL-induced apoptosis in hepatocellular carcinoma cells", Biochem Biophys Res Commun, 418, pp.433~438 (2012)
59. Lafont E, "The linear ubiquitin chain assembly complex regulates TRAIL-induced gene activation and cell death", EMBO J, 36, pp.1147~1166 (2017)
60. Kirisako T, "A ubiquitin ligase complex assembles linear polyubiquitin chains", EMBO J, 25, pp.4877~4887 (2006)
61. Roth W, "FLIP protein and TRAIL-induced apoptosis", Vitam Horm, 67, pp.189~206 (2004)
62. Shirley S, "Targeting c-FLIP in cancer", Cancer Lett, 332, pp.141~150 (2013)
63. Griffith TS, "Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells", J Immunol, 161, pp.2833~2840 (1998)
64. Xiao CW, "Resistance of human ovarian cancer cells to tumor necrosis factor alpha is a consequence of nuclear factor kappaB-mediated induction of Fas-associated death domain-like interleukin-1beta-converting enzyme-like inhibitory protein", Endocrinology, 144, pp.623~630 (2003)
65. Zhang X, "Persistent c-FLIP(L)expression is necessary and sufficient to maintain resistance to tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis in prostate cancer", Cancer Res, 64, pp.7086~7091 (2004)
66. Valnet-Rabier MB, "c-Flip protein expression in Burkitt's lymphomas is associated with a poor clinical outcome", Br J Haematol, 128, pp.767~773 (2005)
67. Valente G, "cFLIP expression correlates with tumour progression and patient outcome in non-Hodgkin lymphomas of low grade of malignancy", Br J Haematol, 132, pp.560~570 (2006)
68. Ullenhag GJ, "Overexpression of FLIPL is an independent marker of poor prognosis in colorectal cancer patients", Clin Cancer Res, 13, pp.5070~5075 (2007)
69. Chang L, "The E3ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L)turnover", Cell, 124, pp.601~613 (2006)
70. Yang F, "Cystatin B inhibition of TRAIL-induced apoptosis is associated with the protection of FLIP(L)from degradation by the E3 ligase itch in human melanoma cells", Cell Death Differ, 17, pp.1354~1367 (2010)
71. Seo BR, "Inhibition of cathepsin s induces mitochondrial ros that sensitizes trail-mediated apoptosis through p53-Mediated Downregulation of Bcl-2 and c-FLIP", Antioxid Redox Signal, 27, pp.215~233 (2017)
72. Zhao L, "mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis", Cancer Res, 73, pp.1946~1957 (2013)
73. Hsu TS, "c-FLIP is a target of the E3 ligase deltex1 in gastric cancer", Cell Death Dis, 9, pp.135~ (2018)
74. Haimerl F, "Down-regulation of the de-ubiquitinating enzyme ubiquitin-specific protease 2 contributes to tumor necrosis factor-alpha-induced hepatocyte survival", J Biol Chem, 284, pp.495~504 (2009)
75. Panner A, "Ubiquitinspecific protease 8 links the PTEN-Akt-AIP4 pathway to the control of FLIPS stability and TRAIL sensitivity in glioblastoma multiforme", Cancer Res, 70, pp.5046~5053 (2010)
76. Jeong M, "USP8 suppresses death receptor-mediated apoptosis by enhancing FLIPL stability", Oncogene, 36, pp.458~470 (2017)

관련 논문AI추천